CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research Methodology
1.4.1 Primary research
1.4.2 Secondary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond what to expect by 2025 ($Million)
2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Enzyme extraction processes
3.2.1 Filtration
3.2.2 Centrifugation and sedimentation:
3.2.3 Purification:
3.3 Key findings
3.3.1 Top impacting factors
3.3.2 Top investment pockets
3.3.3 Top winning strategies
3.4 Government regulations
3.5 Value chain analysis
3.5.1.1 Primary Activities
3.5.1.2 Supportive Activities
3.6 Market share analysis, 2014
3.7 Clinical trials
3.8 Patent analysis (2010-2014)
3.8.1 Patent analysis by geographies (2010-2014)
3.8.2 Patent analysis by sub segment (2010-2014)
3.9 Market dynamics
3.9.1 Drivers
3.9.2 Restraints
3.9.3 Opportunities
CHAPTER 4 GLOBAL SPECIALTY ENZYMES FOR PHARMACEUTICALS, BIOTECH R&D AND DIAGNOSTICS MARKET, BY APPLICATION 2014-2020,
4.1 Pharmaceuticals
4.1.1 Key market trends
4.1.2 Market growth factors and opportunities
4.1.3 Market size and forecast
4.2 Biotechnology research and development
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Diagnostics
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
CHAPTER 5 GLOBAL SPECIALTY ENZYMES FOR PHARMACEUTICALS, BIOTECH R&D AND DIAGNOSTICS MARKET BY SOURCE, 2014-2020,
5.1 Microorganisms
5.1.1 Key market trends
5.1.2 Market growth factors and opportunities
5.1.3 Market size and forecast
5.2 Plants
5.2.1 Key market trends
5.2.2 Market growth factors and opportunities
5.2.3 Market size and forecast
5.3 Animal
5.3.1 Key market trends
5.3.2 Market growth factors and opportunities
5.3.3 Market size and forecast
CHAPTER 6 GLOBAL SPECIALTY ENZYMES FOR PHARMACEUTICALS, BIOTECH R&D AND DIAGNOSTICS MARKET BY TYPE, 2014-2020,
6.1 Overview
6.1.1 Market size and forecast
6.2 Acylases
6.2.1 Market size and forecast
6.3 Hydratases
6.3.1 Market size and forecast
6.4 Humulin
6.4.1 Market size and forecast
6.5 Oxidase
6.5.1 Market size and forecast
6.6 Lyases
6.6.1 Market size and forecast
6.7 Restriction enzymes
6.7.1 Market size and forecast
6.8 Ligases
6.8.1 Market size and forecast
6.9 Polymerases
6.9.1 Market size and forecast
6.10 Lipases
6.10.1 Market size and forecast
6.11 Amylases
6.11.1 Market size and forecast
6.12 Proteases
6.12.1 Market size and forecast
6.13 Dehydrogenases
6.13.1 Market size and forecast
6.14 Glucuronidases
6.14.1 Market size and forecast
6.15 Others
6.15.1 Market size and forecast
CHAPTER 7 GLOBAL SPECIALTY ENZYMES FOR PHARMACEUTICALS, BIOTECH R&D AND DIAGNOSTICS MARKET BY GEOGRAPHY, 2014-2020,
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key market trends
7.2.2 Competitive scenario
7.2.3 Key growth factors and opportunities
7.2.4 Market size and forecast
7.3 Europe
7.3.1 Key market trends
7.3.2 Competitive scenario
7.3.3 Key growth factors and opportunities
7.3.4 Market size and forecast
7.4 Asia-Pacific
7.4.1 Key market trends
7.4.2 Competitive scenario
7.4.3 Key growth factors and opportunities
7.4.4 Market size and forecast
7.5 LAMEA
7.5.1 Key market trends
7.5.2 Competitive scenario
7.5.3 Key growth factors and opportunities
7.5.4 Market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1 Roche Holding AG
8.1.1 Overview
8.1.2 Company snapshot of Roche Holding Ag
8.1.3 Financial performance of Roche Holding Ag.
8.1.4 Strategic moves and developments
8.1.5 SWOT analysis of Roche Holding Ag.
8.2 Sanofi S.A.
8.2.1 Overview
8.2.2 Company snapshot Sanofi S.A.
8.2.3 Financial performance
8.2.4 Strategic moves and developments
8.2.5 SWOT analysis of Sanofi SA
8.3 BASF
8.3.1 Overview
8.3.2 Company snapshot
8.3.3 Financial performance
8.3.4 Strategic moves and developments
8.3.5 SWOT analysis of BASF
8.4 Advanced Enzyme Technology Ltd.
8.4.1 Overview
8.4.2 Company snapshot
8.4.3 Financial performance
8.4.4 Strategic moves and developments
8.4.5 SWOT analysis of Advanced Enzymes Technologies
8.5 BBI Enzymes Ltd.
8.5.1 Overview
8.5.2 Company snapshot.
8.5.3 Strategic moves and developments
8.5.4 SWOT analysis
8.6 Affymetrix Inc.
8.6.1 Overview
8.6.2 Company snapshot
8.6.3 Financial performance
8.6.4 Strategic moves and developments
8.6.5 SWOT analysis
8.7 Codexis Inc.
8.7.1 Overview
8.7.2 Company snapshot
8.7.3 Financial performance
8.7.4 Strategic moves and developments
8.7.5 SWOT analysis.
8.8 Novozymes
8.8.1 Overview
8.8.2 Company snapshot
8.8.3 Financial performance
8.8.4 Strategic moves and developments
8.8.5 SWOT analysis
8.9 DuPont
8.9.1 DuPont Overview
8.9.2 Company snapshot
8.9.3 Financial performance
8.9.4 Strategic moves and developments
8.9.5 Swot analysis
8.10 AB Enzymes
8.10.1 Ab Enzymes Overview
8.10.2 Company snapshot
8.10.3 Strategic moves and developments
8.10.4 Swot analysis